Dermatology, MOHS-Micrographic Surgery · Columbus, GA
NPI
1336146091
Since 2005
Specialty
Dermatology, MOHS-Micrographic Surgery
Code 207ND0101X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1210 Brookstone Centre Parkway
Columbus, GA, 31904
Phone (706) 322-1717
Groups this clinician bills Medicare through
Medicare paid, 2024
$891K
4,816 services
Medicare patients, 2024
854
Average age 77
Drug cost, 2024
$905K
694 prescriptions
Company payments, 2025
$1,428
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joshua E Lane was code Q4159 (affinity, per square centimeter), 795 times for 21 patients. In total Joshua E Lane billed 4,816 services in 95 codes, and Medicare paid $891K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q4159 Affinity, per square centimeter | Office | 795 | 21 | $214.35 | $170K |
| 17311 Mohs Surgery | Office | 553 | 447 | $467.46 | $259K |
| 17003 Destruction Skin Lesion | Office | 309 | 74 | $3.64 | $1,124 |
| 99213 Office E&M - Established | Office | 299 | 216 | $58.52 | $17K |
| 13132 Wound Repair - All Levels | Facility | 255 | 225 | $111.40 | $28K |
| 17312 Mohs Surgery | Office | 240 | 181 | $295.34 | $71K |
| 99212 Office E&M - Established | Office | 215 | 138 | $39.60 | $8,514 |
| J9190 Injection, fluorouracil, 500 mg | Office | 200 | 15 | $1.41 | $282 |
| 12032 Wound Repair - All Levels | Facility | 152 | 144 | $84.90 | $13K |
| 17000 Destruction Skin Lesion | Office | 128 | 113 | $31.92 | $4,086 |
| 11102 Skin Biopsy | Office | 91 | 89 | $55.07 | $5,012 |
| 99214 Office E&M - Established | Office | 75 | 67 | $78.18 | $5,863 |
| 15275 Skin and Soft Tissue Substitutes | Office | 71 | 21 | $113.17 | $8,035 |
| 13121 Wound Repair - All Levels | Facility | 71 | 69 | $95.32 | $6,768 |
| 17313 Mohs Surgery | Office | 69 | 64 | $426.93 | $29K |
By year: 2022 $631K for 6,507 services; 2023 $644K for 4,671 services; 2024 $891K for 4,816 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joshua E Lane prescribed most often to Medicare patients was Clobetasol Propionate, with 122 prescriptions and refills. In total Joshua E Lane wrote 694 Medicare prescriptions that cost $905K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobetasol Propionate Generic | 122 | 139 | 99 | $5,759 |
| Doxycycline Hyclate Generic | 73 | 75 | 48 | $1,130 |
| Triamcinolone Acetonide Generic | 72 | 76 | 59 | $1,361 |
| Fluorouracil Generic | 69 | 75 | 65 | $4,727 |
| Odomzo Sonidegib Phosphate | 52 | 52 | 14 | $682K |
| Ketoconazole Generic | 33 | 33 | 20 | $456 |
| Clindamycin Phosphate Generic | 28 | 33 | 17 | $697 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 25 | 25 | 19 | $148 |
| Cephalexin Generic | 21 | 21 | 21 | $68.62 |
| Desonide Generic | 17 | 18 | 14 | $790 |
| Doxycycline Monohydrate Generic | 13 | 15 | Under 11 | $118 |
| Fluocinonide Generic | 13 | 16 | Under 11 | $440 |
| Dupixent Pen Dupilumab | 11 | 11 | Under 11 | $41K |
Brand drugs: 90 claims; generic drugs: 604 claims; opioid claims: 27.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joshua E Lane $1,428 ($1,428 in general payments such as food, travel and fees) from 18 companies. The largest payer was Abbvie Inc. with $369.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 16 | $369 |
| Galderma Laboratories, L.P. GALD.SW | 8 | $217 |
| Genzyme Corporation SNY | 8 | $199 |
| Regeneron Healthcare Solutions, Inc. REGN | 6 | $136 |
| Janssen Biotech, Inc. JNJ | 1 | $99.99 |
| LEO Pharma Inc. | 3 | $75.57 |
| Pfizer Inc. PFE | 4 | $73.65 |
| Kerecis Limited | 3 | $62.41 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $45.4 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $39.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.